1-4 of 4
Meng Wu
Close
Sort by
Journal Articles

A Dose Escalation Phase Ia Study of Anti-CD20 Antibody Drug Conjugate, MRG001 in Relapsed/Refractory Advanced Non-Hodgkin Lymphom

Yuqin Song, Ye Guo, Zhao Wang, Meng Wu, Wei Peng, Lei Sun, Jinghui Sun, Maggie Li, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2490.
https://doi.org/10.1182/blood-2021-144829
Published: 2021
Journal Articles

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients in China in the Rituximab Era

Yun Li, MD PhD, Meng Wu, MD, Huiqiang Huang, MD PhD, Wei Xu, MD PhD, Haiwen Huang, MD PhD, Weili Zhao, MD PhD, Yanyan Wang, MD, Shuo Liu, MD, Pengpeng Xu, MD, Zhengming Chen, Yuqin Song, MD PhD, Jia Ruan, MD PhD, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3994.
https://doi.org/10.1182/blood-2019-125192
Published: 2019
Journal Articles

A Retrospective Study of 108 Cases of Relapsed or Refractory Classical Hodgkin Lymphoma: Second Line Therapies and Autologous Hematopoietic Stem Cell Transplantation

Mingzi Yang, MD, Meng Wu, MD, Reyizha Nuersulitan, MD, Yanfei Liu, MD, Liya A, MD, Lingyan Ping, MD PhD, Yuqin Song, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5361.
https://doi.org/10.1182/blood-2018-99-112385
Published: 2018
Journal Articles

The WASP P460S Mutation Causes a New Phenotype of WASP Mutations Related Disorder: X-Linked Pancytopenia

Yunjing Zheng, MD, Shuiyan Wu, Xiaoliang Yu, Meng Wu, Qin Lu, Sudan He, Shaoyan Hu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1044.
https://doi.org/10.1182/blood.V130.Suppl_1.1044.1044
Published: 2017